IRIS
CHITI, ARTURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.960
AS - Asia 4.372
EU - Europa 2.272
SA - Sud America 1.089
AF - Africa 419
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 22.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.702
SG - Singapore 2.606
BR - Brasile 949
CN - Cina 944
FI - Finlandia 547
IE - Irlanda 399
NG - Nigeria 347
DE - Germania 285
IT - Italia 222
CA - Canada 194
FR - Francia 179
IN - India 158
VN - Vietnam 156
GB - Regno Unito 136
HK - Hong Kong 134
SE - Svezia 132
NL - Olanda 125
TR - Turchia 99
RU - Federazione Russa 60
IL - Israele 59
BE - Belgio 57
AR - Argentina 55
BD - Bangladesh 39
MX - Messico 35
IQ - Iraq 31
ZA - Sudafrica 29
PL - Polonia 25
EC - Ecuador 22
ES - Italia 21
JP - Giappone 20
ID - Indonesia 15
CL - Cile 14
CO - Colombia 14
UA - Ucraina 14
AT - Austria 13
IR - Iran 13
MA - Marocco 12
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
JM - Giamaica 9
KE - Kenya 9
KG - Kirghizistan 9
PE - Perù 9
PK - Pakistan 9
CZ - Repubblica Ceca 8
EU - Europa 8
PY - Paraguay 8
TW - Taiwan 8
UY - Uruguay 8
EG - Egitto 7
UZ - Uzbekistan 7
VE - Venezuela 7
KZ - Kazakistan 6
TN - Tunisia 6
AU - Australia 5
EE - Estonia 5
JO - Giordania 5
NP - Nepal 5
RO - Romania 5
CH - Svizzera 4
GT - Guatemala 4
LT - Lituania 4
NZ - Nuova Zelanda 4
PA - Panama 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DO - Repubblica Dominicana 3
HR - Croazia 3
MT - Malta 3
MY - Malesia 3
NI - Nicaragua 3
PH - Filippine 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
GR - Grecia 2
HN - Honduras 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GI - Gibilterra 1
Totale 22.121
Salva come PNG Salva come JPEG
Città #
Dallas 2.207
Wilmington 2.003
Chandler 1.871
Singapore 827
San Mateo 775
The Dalles 689
Ann Arbor 608
Helsinki 543
Shanghai 527
Ashburn 434
Leawood 399
Dublin 398
Boardman 354
Benin City 346
Lawrence 326
Princeton 326
Beijing 225
New York 207
Fairfield 193
Woodbridge 181
Toronto 166
Paris 162
Amsterdam 113
Hong Kong 108
Pune 96
São Paulo 85
London 82
Kocaeli 79
Milan 78
Seattle 75
Los Angeles 66
Ho Chi Minh City 60
Brussels 56
San Diego 56
Santa Clara 51
Norwalk 49
Monmouth Junction 44
Rio de Janeiro 37
Munich 34
Council Bluffs 32
Moscow 31
Phoenix 31
Brooklyn 30
Falls Church 30
Hanoi 29
Belo Horizonte 21
Houston 21
Warsaw 21
Campinas 18
Johannesburg 18
Atlanta 17
Redmond 15
Brasília 14
Chennai 14
Redwood City 14
San Francisco 14
Boston 13
Dhaka 13
Osasco 13
Porto Alegre 13
Tokyo 13
Curitiba 12
Goiânia 12
Montreal 12
Stockholm 12
Chicago 11
Falkenstein 11
Guarulhos 11
Cambridge 10
Des Moines 10
Mumbai 10
Naples 10
Zhengzhou 10
Berlin 9
Columbus 9
Da Nang 9
Denver 9
Fortaleza 9
Mexico City 9
Tappahannock 9
Bishkek 8
Düsseldorf 8
Erbil 8
Kingston 8
Ribeirão Preto 8
Terracina 8
Vienna 8
Abbiategrasso 7
Andover 7
Ankara 7
Baghdad 7
Camaçari 7
Charlotte 7
Florence 7
Guayaquil 7
Joinville 7
Montevideo 7
Poplar 7
Tashkent 7
Uberlândia 7
Totale 15.712
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 609
111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer 587
111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer. 570
11Cl-choline PET/CT in imaging locally advanced prostate cancer 556
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 134
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy 129
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 106
Applications of PET imaging with radiolabelled choline (C-11/F-18-choline) 105
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 99
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 99
A portrait of the scientist as a young woman Comments after the first EANM Young Investigators' Meeting 96
[F-18] FDG PET/CT features for the molecular characterization of primary breast tumors 96
A case of metastatic axillary lymph nodes involvement from unknown primary cancer: Clinical usefulness of [Tc-99m]-sestamibi 96
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 94
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 92
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy 89
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 86
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 85
Correlation of microvascular fractal dimension with positron emission tomography [C-11]-methionine uptake in glioblastoma multiforme: Preliminary findings 84
Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy 84
A risk management approach for imaging biomarker-driven clinical trials in oncology 84
A DOUBTFUL IMAGE OF LEVEEN SHUNT PATENCY 83
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 82
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 81
A case of atypical giant cell arteritis diagnosed by positron emission tomography (PET) 81
INDIUM-111-DTPA-OCTREOTIDE SCINTIGRAPHY MODULATION BY TREATMENT WITH UNLABELED SOMATOSTATIN ANALOG IN SMALL-CELL LUNG-CANCER 80
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 80
F-18-DOPA PET/CT in Neuroblastoma Comparison of Conventional Imaging With CT/MR 79
I-131/I-123-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging 79
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 79
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning 79
Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals 78
C-11-Methionine uptake in secondary brain epilepsy 78
Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases 78
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 78
PREDICTIVE VALUE OF EARLY PET DURING SALVAGE CHEMOTHERAPY IN RELAPSING/REFRACTORY HODGKIN'S LYMPHOMA (HL) PATIENTS 78
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 77
Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: Can positron emission tomography (PET) with F-18-FDG be considered as the best method? 76
A method to reduce acetonitrile amount in F-18-FDG synthesis 76
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 76
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 76
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 76
Evaluation of response: is F-18-FDG PET the answer? 75
Role of I-131-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours - Experience of the National Cancer Institute of Milan 75
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 75
[C-11] Choline PET/CT Impacts Treatment Decision Making in Patients With Prostate Cancer Referred for Radiotherapy 75
Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail 74
Bone lesion in a patient with transplanted liver for a metastatic carcinoid. The role of somatostatin receptor scintigraphy 74
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 74
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 74
Chest CT in patients with a moderate or high pretest probability of COVID-19 and negative swab 74
Pancreatic cancer or chronic pancreatitis? An answer from PET/MRI image fusion 73
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine 73
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 72
Prognostic significance of molecular and imaging biomarkers in primary brain tumors 72
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 72
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 72
Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours 72
Assessment of tumor response in malignant pleural mesothelioma 71
PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014 71
FDG-PET as a tool to optimize residual surgery in patients with primary extragonadal germ cell tumors: preliminary results 71
EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma 71
The Path to the Future: Education of Nuclear Medicine Therapeutic Specialists as Responsible Physicians 70
Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer. Eur Urol 2011;59:572-83 70
Molecular Imaging in Radiotherapy Planning for Head and Neck Tumors 70
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 69
C-11-labeled methionine and evaluation of malignant pleural mesothelioma 69
Procedure guidelines for PET/CT tumour imaging with Ga-68-DOTA-conjugated peptides: Ga-68-DOTA-TOC, Ga-68-DOTA-NOC, Ga-68-DOTA-TATE 69
Radiopharmaceuticals for breast cancer imaging 69
Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT 69
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 69
Multimodal Characterization of Supratentorial Gliomas: Relationship Among Morphological, Metabolic and Molecular features 69
Utility of gallium-67 in determining the radicality of lymph node dissections of the neck for metastatic lymph nodes with extranodal spread in patients affected by carcinoma of the head and neck 69
Exploration of Disease Markers under Translational Medicine Model 68
F-18-FDG PET/CT scans for children and adolescents 68
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 68
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology 67
New Clinical Indications for F-18/C-11-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature 67
F-18-FDG-PET (PET) and contrast-enhanced CT-scan (CT) in the evaluation of liver metastases from colorectal cancer after chemotherapy 67
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma 67
SEGMENTAL FDG-PET/CT IN SOLITARY PULMONARY NODULE: PRELIMINARY DATA OF THE PET ITALIAN TRIAL 66
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 66
Prognostic and predictive role of [F-18]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy 66
Consensus on molecular imaging and theranostics in prostate cancer 66
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 66
CASE-REPORT - TECHNETIUM-99M-HEXAKIS-2-METHOXY-ISOBUTYL-ISONITRILE IMAGING OF BREAST-CANCER AND MYOCARDIAL-INFARCTION IN THE SAME PATIENT 66
Targeted PET/TRUS software fusion‑guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: A feasibility study and preliminary results 66
In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging 65
PRELIMINARY-RESULTS OF PREOPERATIVE AXILLARY RADIOIMMUNOSCINTIGRAPHY WITH IN-111 B72.3 IN BREAST-CANCER 65
The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors | [La scintigrafia dei recettori per la somatostatina nei tumori neuroendocrini gastro-entero-pancreatici.] 65
Standardization and quantification in PET/CT imaging: tracers beyond FDG. 65
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines 65
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 65
Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [F-18]fluorodeoxyglucose 65
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 65
PET/CT radiomics in breast cancer: Mind the step 65
FDG PET/CT predictive role in follicular lymphoma 64
Nuclear medicine procedures in lung cancer 64
Comments on the Italian Society of Endocrinology recommendations on post-surgical thyroid ablation in differentiated thyroid cancer 64
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 64
Totale 9.627
Salva come PNG Salva come JPEG
Categoria #
all - tutte 164.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.844
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.689 0 0 0 0 0 1.222 543 277 732 498 38 379
2021/20221.911 160 17 60 413 37 28 73 259 161 129 484 90
2022/20235.082 745 194 460 556 455 460 10 409 944 429 344 76
2023/20242.612 218 319 581 172 62 299 150 129 50 35 239 358
2024/20253.414 90 71 28 41 61 429 191 380 431 882 411 399
2025/20265.385 1.378 758 1.964 916 280 89 0 0 0 0 0 0
Totale 22.300